Featured Interviews

Xortx Therapeutics (CSE: XRX) (OTCQB: XRTXF)

Xortx CEO Dr. Allen Davidoff took time to update investors on the company’s accomplishments over the last several months. XRX just announced a partnership with Mount Sinai’s Icahn school of medicine for a US based COVID-19 clinical trial for acute kidney injury associated with the virus. […]